BR0210875A - Antìgenos de streptococcus do grupo b e fragmentos de dna correspondentes - Google Patents
Antìgenos de streptococcus do grupo b e fragmentos de dna correspondentesInfo
- Publication number
- BR0210875A BR0210875A BR0210875-5A BR0210875A BR0210875A BR 0210875 A BR0210875 A BR 0210875A BR 0210875 A BR0210875 A BR 0210875A BR 0210875 A BR0210875 A BR 0210875A
- Authority
- BR
- Brazil
- Prior art keywords
- group
- dna fragments
- corresponding dna
- antigens
- streptococcus
- Prior art date
Links
- 241000193990 Streptococcus sp. 'group B' Species 0.000 title abstract 4
- 239000000427 antigen Substances 0.000 title abstract 4
- 102000036639 antigens Human genes 0.000 title abstract 4
- 108091007433 antigens Proteins 0.000 title abstract 4
- 239000012634 fragment Substances 0.000 title abstract 2
- 241000194017 Streptococcus Species 0.000 abstract 1
- 241000193985 Streptococcus agalactiae Species 0.000 abstract 1
- 238000003745 diagnosis Methods 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/975—Kit
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Biophysics (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Oncology (AREA)
- Public Health (AREA)
- Communicable Diseases (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US30310101P | 2001-07-06 | 2001-07-06 | |
| PCT/CA2002/001019 WO2003004650A2 (en) | 2001-07-06 | 2002-07-05 | Group b streptococcus antigens and corresponding dna fragments |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR0210875A true BR0210875A (pt) | 2004-06-22 |
Family
ID=23170538
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR0210875-5A BR0210875A (pt) | 2001-07-06 | 2002-07-05 | Antìgenos de streptococcus do grupo b e fragmentos de dna correspondentes |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US7393536B2 (enExample) |
| EP (1) | EP1407023B1 (enExample) |
| JP (2) | JP4374245B2 (enExample) |
| AT (1) | ATE452191T1 (enExample) |
| AU (1) | AU2002317107B2 (enExample) |
| BR (1) | BR0210875A (enExample) |
| CA (1) | CA2453062C (enExample) |
| DE (1) | DE60234772D1 (enExample) |
| ES (1) | ES2337773T3 (enExample) |
| WO (1) | WO2003004650A2 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002034771A2 (en) * | 2000-10-27 | 2002-05-02 | Chiron Srl | Nucleic acids and proteins from streptococcus groups a & b |
| AU1686302A (en) * | 2000-12-21 | 2002-07-01 | Shire Biochem Inc | Streptococcus pyogenes antigens and corresponding dna fragments |
| JP2005514052A (ja) * | 2001-12-21 | 2005-05-19 | チルドレンズ ホスピタル アンド レジオナル メディカル センター | Ｂ群連鎖球菌の新規の細胞表面プロテアーゼの使用 |
| US8877909B2 (en) | 2011-04-04 | 2014-11-04 | Intelligent Medical Devices, Inc. | Optimized oligonucleotides and methods of using same for the detection, isolation, amplification, quantitation, monitoring, screening, and sequencing of group B Streptococcus |
| KR101675382B1 (ko) | 2015-04-07 | 2016-11-14 | (주) 씨에스코리아 | 황토보드 제조방법 및 그에 의해 제조되는 황토보드 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1994006465A1 (en) | 1992-09-16 | 1994-03-31 | The University Of Tennessee Research Corporation | Antigen of hybrid m protein and carrier for group a streptococcal vaccine |
| ATE349527T1 (de) | 1997-09-12 | 2007-01-15 | Univ Tennessee Res Foundation | Gruppe a streptokokken-impfstoff |
| ATE394489T1 (de) * | 1998-12-23 | 2008-05-15 | Id Biomedical Corp | Streptococcus antigene |
| GB9921125D0 (en) | 1999-09-07 | 1999-11-10 | Microbial Technics Limited | Proteins |
| WO2002034771A2 (en) * | 2000-10-27 | 2002-05-02 | Chiron Srl | Nucleic acids and proteins from streptococcus groups a & b |
| FR2824074A1 (fr) | 2001-04-26 | 2002-10-31 | Pasteur Institut | Sequence du genome streptococcus agalactiae, application au developpement de vaccins, d'outils de diagnostic, et a l'identification de cibles therapeutiques |
| AU2002351623A1 (en) | 2001-12-20 | 2003-07-09 | Shire Biochem Inc. | Streptococcus antigens |
-
2002
- 2002-07-05 CA CA2453062A patent/CA2453062C/en not_active Expired - Fee Related
- 2002-07-05 AU AU2002317107A patent/AU2002317107B2/en not_active Ceased
- 2002-07-05 US US10/482,929 patent/US7393536B2/en not_active Expired - Lifetime
- 2002-07-05 DE DE60234772T patent/DE60234772D1/de not_active Expired - Lifetime
- 2002-07-05 BR BR0210875-5A patent/BR0210875A/pt active Search and Examination
- 2002-07-05 AT AT02745009T patent/ATE452191T1/de not_active IP Right Cessation
- 2002-07-05 WO PCT/CA2002/001019 patent/WO2003004650A2/en not_active Ceased
- 2002-07-05 EP EP02745009A patent/EP1407023B1/en not_active Expired - Lifetime
- 2002-07-05 ES ES02745009T patent/ES2337773T3/es not_active Expired - Lifetime
- 2002-07-05 JP JP2003510808A patent/JP4374245B2/ja not_active Expired - Fee Related
-
2008
- 2008-06-09 US US12/135,911 patent/US7740870B2/en not_active Expired - Lifetime
-
2009
- 2009-06-10 JP JP2009139587A patent/JP5194199B2/ja not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US20040242844A1 (en) | 2004-12-02 |
| AU2002317107B2 (en) | 2008-06-12 |
| DE60234772D1 (de) | 2010-01-28 |
| ES2337773T3 (es) | 2010-04-29 |
| WO2003004650A3 (en) | 2003-05-30 |
| US7393536B2 (en) | 2008-07-01 |
| EP1407023A2 (en) | 2004-04-14 |
| JP5194199B2 (ja) | 2013-05-08 |
| JP2009240316A (ja) | 2009-10-22 |
| US20090042794A1 (en) | 2009-02-12 |
| CA2453062A1 (en) | 2003-01-16 |
| ATE452191T1 (de) | 2010-01-15 |
| JP2005501534A (ja) | 2005-01-20 |
| EP1407023B1 (en) | 2009-12-16 |
| CA2453062C (en) | 2013-04-02 |
| WO2003004650A2 (en) | 2003-01-16 |
| JP4374245B2 (ja) | 2009-12-02 |
| US7740870B2 (en) | 2010-06-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2001058485A3 (en) | Prophylactic and therapeutic antibodies against vaccina virus antigens | |
| WO2003054007A3 (en) | Streptococcus antigens | |
| BR0116370A (pt) | Composto, composição farmacêutica, uso de um composto, e, método de tratamento de uma doença ou condição mediada por hppar em um paciente. | |
| BR0213540A (pt) | Compostos, método para o tratamento de enfermidades ou distúrbios em um paciente e composição farmacêutica que compreende os mesmos | |
| DE60210456D1 (de) | Solubisierung von kapseln polysacchariden | |
| ATE470676T1 (de) | Anti-vegf-2 antikörper | |
| BR0104830A (pt) | Tratamento de combinação para a demência ou déficits cognitivos associados com a doença de alzheimer e com a doença de parkinson | |
| DE602004024542D1 (de) | Untereinheit-impfstoff gegen das respiratorische synzytialvirus | |
| BR0208142A (pt) | Combinações compreendendo um agente antidiarréico e epotilona ou derivado de epotilona | |
| ATE325620T1 (de) | Streptococcus pneumoniae proteine und impfstoffe | |
| BR0207487A (pt) | Método de tratamento de tumores em mamìferos e uso de compostos de epotilona | |
| WO2006065553A3 (en) | Glycoconjugate vaccines containing peptidoglycan | |
| BR0209845A (pt) | Formas de dosagem de oxcarbazepina e processo para a preparação das mesmas | |
| WO2001058476A3 (en) | Methods and compositions for treatment of alzheimer's disease by enhancing plasmin or plasmin-like activity | |
| PT932613E (pt) | Expressao de bloqueio de factoes de virulencia em s. aureus | |
| WO2000058475A3 (en) | Streptococcus pneumoniae antigens | |
| BR0201524A (pt) | Tratamento de combinação para ansiedade e depressão | |
| BR0109164A (pt) | Anticorpos monoclonais para o receptor humano para ldl, produção e uso dos mesmos | |
| BR0210875A (pt) | Antìgenos de streptococcus do grupo b e fragmentos de dna correspondentes | |
| BRPI0414139A (pt) | métodos e composições para tratar infecções por herpes | |
| BR0201889A (pt) | Vacinas de ige não-anafilactogênicas | |
| EP0955366A4 (en) | ANTIGENIC PROTEIN FROM MALASSEZIA | |
| BR0207447A (pt) | Polipeptìdeos e fragmentos de dna correspondentes de streptococcus pyogenes úteis como componentes de vacina | |
| WO2000063386A3 (en) | Prevention, diagnosis and treatment of lyme disease | |
| ATE420852T1 (de) | Verfahren und zusammensetzungen zur behandlung oder prävention von bakteriellen infektionen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B25G | Requested change of headquarter approved |
Owner name: SHIRE BIOCHEM INC. (CA) Free format text: ALTERADA A SEDE DO TITULAR CONFORME REQUERIDA ATRAVES DA PETICAO NO 020050112623/RJ DE 11/10/2005. |
|
| B25A | Requested transfer of rights approved |
Owner name: ID BIOMEDICAL CORPORATION (CA) Free format text: TRANSFERIDO DE: SHIRE BIOCHEM INC. |
|
| B25G | Requested change of headquarter approved |
Owner name: ID BIOMEDICAL CORPORATION (CA) Free format text: SEDE ALTERADA CONFORME SOLICITADO NA PETICAO NO 020070097786/RJ DE 17/07/2007. |
|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B25A | Requested transfer of rights approved |
Owner name: ID BIOMEDICAL CORPORATION OF QUEBEC (CA) |
|
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B11D | Dismissal acc. art. 38, par 2 of ipl - failure to pay fee after grant in time |